nach oben

Reactions Weekly

Erschienen in:

01.07.2019 | Case report

Raltegravir

Various toxicities: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

In an observational, prospective cohort study performed between June 2015−June 2016, two patients [ages and sexes not stated] were described, of whom one patient developed nausea, diarrhoea and another patient developed myalgia and elevated levels of serum creatine kinase during treatment with raltegravir for HIV. …

Calza L, et al. Improvement in insulin sensitivity and serum leptin concentration after the switch from a ritonavir-boosted PI to raltegravir or dolutegravir in non-diabetic HIV-infected patients. Journal of Antimicrobial Chemotherapy 74: 731-738, No. 3, Mar 2019. Available from: URL: http://doi.org/10.1093/jac/dky507 - Italy

Titel: Raltegravir
Various toxicities: 2 case reports
Publikationsdatum: 01.07.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-64697-9

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Raltegravir

Various toxicities: 2 case reports

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

Antipsychotics

Gemifloxacin

Enoxaparin sodium

Oxcarbazepine

Cetirizine

Fluorouracil/folinic acid/oxaliplatin